ArticleContemporary clinical trials communications2022
Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp).
Mark B Lockwood et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.